Immunosuppressant therapy with tacrolimus and cyclosporine in lung transplant recipients and cytomegalovirus infection: a retrospective review

被引：0
|
作者：
Nogueiras Alvarez, R. [1 ]
Mazon Marana, I. [1 ]
Vega Gil, N. [1 ]
Vaca Recalde, G. [1 ]
Ortiz Petrosino, P. [1 ]
Mora Cuesta, V. M. [2 ]
Bautista Blazquez, A. [1 ]
Cuellar Gomez, D. Z. [1 ]
Sanchez Santiago, B. [1 ]
机构：
[1] Hosp Univ Marques Valdecilla, Farmacol Clin, Santander, Spain
[2] Hosp Univ Marques Valdecilla, Neumol, Santander, Spain
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2019年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
EACPT-1267
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [1] TACROLIMUS VS CYCLOSPORINE AS PRIMARY MAINTENANCE IMMUNOSUPPRESSANT FOR LUNG TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Haddad, Ibrahim
    Thomas, Akesh
    Karakattu, Sajin
    Cornwell, Kevin
    CHEST, 2020, 158 (04) : 2404A - 2404A
  • [2] TACROLIMUS OR CYCLOSPORINE: WHICH IS THE BETTER MAINTENANCE IMMUNOSUPPRESSANT FOR KIDNEY TRANSPLANT RECIPIENTS?
    Seungyeup, Han
    Yaerim, Kim
    Sungbae, Park
    Hyungtae, Kim
    NEPHROLOGY, 2014, 19 : 113 - 113
  • [3] Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
    Teixeira Da Silva, David Tavares
    Dantas, Carolina
    Emiliano, Madalena
    Semedo, Luisa
    Cardoso, Joao
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Cytomegalovirus infection in lung transplant recipients
    Almaghrabi, Reem S.
    Omrani, Ali S.
    Memish, Ziad A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (05) : 377 - 383
  • [5] Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study
    Veit, Tobias
    Munker, Dieter
    Barton, Juergen
    Milger, Katrin
    Kauke, Teresa
    Meiser, Bruno
    Michel, Sebastian
    Zoller, Michael
    Nitschko, Hans
    Keppler, Oliver T.
    Behr, Jurgen
    Kneidinger, Nikolaus
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (10) : 3449 - 3455
  • [6] Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
    Mansell, Holly
    Shoker, Ahmed
    Alcorn, Jane
    Fenton, Mark E.
    Tam, Julian S.
    Semchuk, William
    Bashir, Babar
    Kraft, Walter K.
    Yao, Shenzhen
    Douketis, James D.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (07): : 1687 - 1697
  • [7] Cytomegalovirus Infection and Disease in Lung Transplant Recipients
    Lynch, B. L.
    Ging, P.
    Ronayne, A.
    De Gascun, C.
    Kleinerova, J.
    Egan, J. J.
    Hannan, M. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S312 - S312
  • [8] Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients
    Barten, MJ
    Rahmel, A
    Garbade, J
    Bold, A
    Bittner, HB
    Dhein, S
    Mohr, FW
    Gummert, JF
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4532 - 4534
  • [9] Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients
    Gerna, G.
    Lilleri, D.
    Rognoni, V.
    Agozzino, M.
    Meloni, F.
    Oggionni, T.
    Pellegrini, C.
    Arbustini, E.
    D'Armini, A. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1142 - 1150
  • [10] Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy
    Chisholm, MA
    Mulloy, LL
    DiPiro, JT
    CLINICAL TRANSPLANTATION, 2005, 19 (01) : 77 - 82
12345